Bo Jesper Hansen
Chairman
oncology
Azanta
Denmark
Biography
Bo Jesper Hansen is Chairman of Sobi AB (Swedish Orphan Biovitrum) a leading integrated biopharmaceutical company with innovative therapies and services, and a diversified and growth-oriented product portfolio. Bo is also Chairman of Karolinska Development and a Board Director of Newron Pharmaceuticals, Genspera Inc., CMC AB, Orphazyme and Ablynx. Formerly, Bo was CEO at Swedish Orphan International and was the founder of Scandinavian Medical Research and co-founder of Swedish Orphan International. Bo holds an M.D. and a Ph.D. from Copenhagen University
Research Interest
oncology Research
